All News #Library
Quality
Immunitybio Responds To FDA Warning Letter With New Protocols
06 Apr 2026 //
FIERCE PHARMA
Immunitybio Hit With FDA Warning Letter Over Anktiva Promotions
24 Mar 2026 //
FIERCE PHARMA
ImmunityBio gets FDA snub on cancer drug, shares crash
12 May 2023 //
FIERCE PHARMA

Market Place
Sourcing Support